RESUMEN
Although recombination is known to be important to generating diversity in the human malaria parasite P. falciparum, the low efficiencies of transfection and the fact that integration of transfected DNA into chromosomes is observed only after long periods (typically 12 weeks or more) have made it difficult to genetically manipulate the blood stages of this major human pathogen. Here we show that co-transfection of a P. falciparum line with two plasmids, one expressing a green fluorescent protein (gfp) reporter and the other expressing a drug resistance marker (Tgdhfr-ts M23), allowed selection of a population in which about approximately 30% of the parasites produce GFP. In these GFP-producing parasites, the transfected plasmids had recombined into chimeric episomes as large as 20 kb and could be maintained under drug pressure for at least 16 weeks. Our data suggest that chimera formation occurs early (detected by 7--14 days) and that it involves homologous recombination favored by presence of the same P. falciparum 5'hrp3 UTR promoting transcription from each plasmid. This indicates the presence of high levels of homologous recombination activity in blood stage parasites that can be used to drive rapid recombination of newly introduced DNA, study mechanisms of recombination, and introduce genes for trans expression in P. falciparum.
Asunto(s)
Plásmidos/genética , Plasmodium falciparum/genética , Recombinación Genética/genética , Transgenes/genética , Animales , Southern Blotting , ADN Recombinante/genética , Resistencia a Medicamentos/genética , Citometría de Flujo , Genes Reporteros/genética , Marcadores Genéticos/genética , Proteínas Fluorescentes Verdes , Proteínas Luminiscentes/genética , Proteínas Luminiscentes/metabolismo , Masculino , Microscopía Fluorescente , Datos de Secuencia Molecular , Plasmodium falciparum/fisiología , Pirimetamina/farmacología , Mapeo Restrictivo , Transfección , Transformación GenéticaRESUMEN
Administered the WAIS to 76 male college students on two occasions with a retest interval of either 1 week, 1 month, 2 months, or 4 months. Essentially all Verbal, Performance, and Full Scale IQs increased significantly on the retest. Increases in Verbal IQ for the four time intervals were 4.7, 1.8, 2.3, and .8 IQ points, respectively; the latter was the only nonsignificant gain found. The Performance IQ increased by 11.4, 9.8, 8.7, and 8.0 points for each subsequent time period, and the Full Scale IQ increased by 8.0, 5.7, 5.4, and 4.2 points for each respective time period. Test-retest correlations for the four intervals ranged from .91 to .72 for the Verbal IQ, .87 to .79 for the Performance IQ, and .94 to .74 for the Full Scale IQ. The results were pitted against similar test-retest studies, and clinical and research implications were discussed.
Asunto(s)
Práctica Psicológica , Escalas de Wechsler , Humanos , Inteligencia , Masculino , Factores de TiempoRESUMEN
This conceptual article attempts to help health care professionals deepen their understanding of the psychological characteristics of antisocial spinal cord-injured patients that predispose them to injury, being a disruptive influence on the medical floor, oppositional acting out with physicians, and potentially thwarting effective treatment. Group techniques are described that appear to improve the adaptation of these patients to their traumatic injury and hospital environment.
Asunto(s)
Trastorno de Personalidad Antisocial/terapia , Psicoterapia de Grupo , Traumatismos de la Médula Espinal/terapia , Adaptación Psicológica , Adulto , Trastorno de Personalidad Antisocial/complicaciones , Trastorno de Personalidad Antisocial/psicología , Humanos , Relaciones Interpersonales , Proyección , Traumatismos de la Médula Espinal/complicaciones , Traumatismos de la Médula Espinal/psicología , ViolenciaRESUMEN
Lymphotactin is unique among chemokines in that it contains only two of four conserved cysteines and may possess a structure less constrained than other chemokines. The viral chemokine vMIP-II, which presumably has a structure similar to that of CC chemokines has been shown to inhibit many chemokine receptors, but its activity at GPR5/XCR1 has not been described. Interestingly, vMIP-II (but not vMIP-I) was found to be a potent antagonist of lymphotactin activity at GPR5/XCR1, extending the range of chemokine classes that this viral protein is known to inhibit to include the C class chemokine. In addition, we have extended previous analyses of GPR5/XCR1 expression and show that this receptor is expressed in leukocyte cells previously shown to be responsive to lymphotactin.
Asunto(s)
Quimiocinas C , Quimiocinas/metabolismo , Proteínas Inflamatorias de Macrófagos/metabolismo , Proteínas de la Membrana , Receptores de Superficie Celular/metabolismo , Receptores Acoplados a Proteínas G , Proteínas Virales/metabolismo , Animales , Secuencia de Bases , Calcio/metabolismo , Línea Celular , Clonación Molecular , Cartilla de ADN/genética , Expresión Génica , Humanos , Ligandos , Linfocinas/metabolismo , Ratones , Receptores de Superficie Celular/genética , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Sialoglicoproteínas/metabolismo , Distribución TisularRESUMEN
Breast cancer is characterized by a distinct metastatic pattern involving the regional lymph nodes, bone marrow, lung and liver. Tumour cell migration and metastasis share many similarities with leukocyte trafficking, which is critically regulated by chemokines and their receptors. Here we report that the chemokine receptors CXCR4 and CCR7 are highly expressed in human breast cancer cells, malignant breast tumours and metastases. Their respective ligands CXCL12/SDF-1alpha and CCL21/6Ckine exhibit peak levels of expression in organs representing the first destinations of breast cancer metastasis. In breast cancer cells, signalling through CXCR4 or CCR7 mediates actin polymerization and pseudopodia formation, and subsequently induces chemotactic and invasive responses. In vivo, neutralizing the interactions of CXCL12/CXCR4 significantly impairs metastasis of breast cancer cells to regional lymph nodes and lung. Malignant melanoma, which has a similar metastatic pattern as breast cancer but also a high incidence of skin metastases, shows high expression levels of CCR10 in addition to CXCR4 and CCR7. Our findings indicate that chemokines and their receptors have a critical role in determining the metastatic destination of tumour cells.
Asunto(s)
Neoplasias de la Mama/patología , Quimiocinas CXC/metabolismo , Metástasis de la Neoplasia , Receptores CXCR4/metabolismo , Receptores de Quimiocina/metabolismo , Actinas/metabolismo , Animales , Proteínas Sanguíneas/metabolismo , Quimiocina CXCL12 , Quimiotaxis , Humanos , Pulmón/patología , Metástasis Linfática , Ratones , Ratones SCID , Invasividad Neoplásica , Trasplante de Neoplasias , Receptores CCR7 , Receptores CXCR4/antagonistas & inhibidores , Células Tumorales CultivadasRESUMEN
We recently reported the identification of a chemokine (CTACK), which has been renamed CCL27 according to a new systematic chemokine nomenclature. We report that CCL27 binds the previously orphan chemokine receptor GPR-2, as detected by calcium flux and chemotactic responses of GPR-2 transfectants. We renamed this receptor CCR10. Because of the skin-associated expression pattern of CCL27, we focused on the expression of CCL27 and CCR10 in normal skin compared with inflammatory and autoimmune skin diseases. CCL27 is constitutively produced by keratinocytes but can also be induced upon stimulation with TNF-alpha and IL-1beta. CCR10 is not expressed by keratinocytes and is instead expressed by melanocytes, dermal fibroblasts, and dermal microvascular endothelial cells. CCR10 was also detected in T cells as well as in skin-derived Langerhans cells. Taken together, these observations suggest a role for this novel ligand/receptor pair in both skin homeostasis as well as a potential role in inflammatory responses.
Asunto(s)
Quimiocinas CC/metabolismo , Quimiocinas/metabolismo , Proteínas de Unión al GTP/metabolismo , Receptores de Quimiocina/metabolismo , Piel/metabolismo , Secuencia de Aminoácidos , Calcio/metabolismo , Línea Celular , Células Cultivadas , Quimiocina CCL27 , Quimiocinas/biosíntesis , Dermatitis Atópica/inmunología , Dermatitis Atópica/metabolismo , Dermatitis Atópica/patología , Biblioteca de Genes , Humanos , Lupus Eritematoso Sistémico/embriología , Lupus Eritematoso Sistémico/inmunología , Lupus Eritematoso Sistémico/patología , Datos de Secuencia Molecular , Unión Proteica/inmunología , Psoriasis/inmunología , Psoriasis/metabolismo , Psoriasis/patología , Receptores CCR10 , Receptores de Quimiocina/biosíntesis , TransfecciónRESUMEN
We report the identification and characterization of a novel CC chemokine designated CCL28 and its receptor CCR10, known previously as orphan G-protein-coupled receptor GPR2. Human and mouse CCL28 share 83% identity at the amino acid and 76% at the nucleic acid levels. We also identified the mouse homologues of CCL28 and of CCR10, which map to mouse chromosomes 13 and 11, respectively. CCL28 is expressed in a variety of human and mouse tissues, and it appears to be predominantly produced by epithelial cells. Both human and mouse CCL28 induce calcium mobilization in human and mouse CCR10-expressing transfectants. CCL28 desensitized the calcium mobilization induced in CCR10 transfectants by CCL27, indicating that these chemokines share this new chemokine receptor. In vitro, recombinant human CCL28 displays chemotactic activity for resting CD4 or CD8 T cells.
Asunto(s)
Quimiocinas CC/genética , Quimiocinas CC/metabolismo , Quimiocinas/genética , Quimiocinas/metabolismo , Receptores de Quimiocina/metabolismo , Secuencia de Aminoácidos , Animales , Quimiocinas/análisis , Quimiocinas CC/análisis , Clonación Molecular , Humanos , Ligandos , Ratones , Datos de Secuencia Molecular , Receptores CCR10 , Alineación de Secuencia , Homología de Secuencia de AminoácidoRESUMEN
Autoimmunity plays a key role in the immunopathogenesis of psoriasis; however, little is known about the recruitment of pathogenic cells to skin lesions. We report here that the CC chemokine, macrophage inflammatory protein-3 alpha, recently renamed CCL20, and its receptor CCR6 are markedly up-regulated in psoriasis. CCL20-expressing keratinocytes colocalize with skin-infiltrating T cells in lesional psoriatic skin. PBMCs derived from psoriatic patients show significantly increased CCR6 mRNA levels. Moreover, skin-homing CLA+ memory T cells express high levels of surface CCR6. Furthermore, the expression of CCR6 mRNA is 100- to 1000-fold higher on sorted CLA+ memory T cells than other chemokine receptors, including CXCR1, CXCR2, CXCR3, CCR2, CCR3, and CCR5. In vitro, CCL20 attracted skin-homing CLA+ T cells of both normal and psoriatic donors; however, psoriatic lymphocytes responded to lower concentrations of chemokine and showed higher chemotactic responses. Using ELISA as well as real-time quantitative PCR, we show that cultured primary keratinocytes, dermal fibroblasts, and dermal microvascular endothelial and dendritic cells are major sources of CCL20, and that the expression of this chemokine can be induced by proinflammatory mediators such as TNF-alpha/IL-1 beta, CD40 ligand, IFN-gamma, or IL-17. Taken together, these findings strongly suggest that CCL20/CCR6 may play a role in the recruitment of T cells to lesional psoriatic skin.